Pharmalys SRL
0.5 FTEThe score of Pharmalys shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +21 % Total assets -19 % Headcount (avg FTE) +400 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmalys's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 33,413 € | ||||
| Equity | 190,543 € | ||||
| Cash | 10,083 € | ||||
| EBITDA | 87,004 € | ||||
| Total assets | 392,320 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Pharmalys's financial analysis
- Solvency48.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmalys
Pharmalys's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0897.510.415
- VAT number
- BE0897510415
- Peppol
- Registered · 0208:0897510415 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Apr 2008
- Registered office
- 6240 Farciennes
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmalys (SRL) has been based in Farciennes since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,413 € and equity of 190,543 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.6%, above the median of its sector (41.5%).
Companies similar to Pharmalys
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Schoonejans Retail sale of pharmaceutical products Saint-Gilles · balance sheet 392,692 €
- Apotheek Peeters Retail sale of pharmaceutical products Tienen · balance sheet 391,521 €
- Balans Retail sale of pharmaceutical products Holsbeek · balance sheet 393,498 €
- Les Pharmacies Réunies Retail sale of pharmaceutical products Frameries · balance sheet 389,988 €
- Minphar Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 396,164 €
- Farmalia Retail sale of pharmaceutical products Etterbeek · balance sheet 397,775 €
- J-C Grace Pharmacy Retail sale of pharmaceutical products Brussels · balance sheet 386,831 €
- Anfarma Retail sale of pharmaceutical products Antwerp · balance sheet 386,780 €
Frequently asked questions about Pharmalys
What is the revenue of Pharmalys?
Pharmalys files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmalys?
In Belgium, the VAT number is the company number prefixed with BE: BE0897510415 for Pharmalys, if the company is VAT-registered. Its company number (CBE) is 0897.510.415.
Where is the registered office of Pharmalys?
According to the CBE register, the registered office of Pharmalys is in 6240 Farciennes.
What is the equity of Pharmalys?
At the close of the 2025 financial year, the equity of Pharmalys amounts to 190,543 €, a solvency of 48.6% of total assets.
How many people work at Pharmalys?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmalys?
The register lists 2 active mandates at Pharmalys. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmalys
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →